152 related articles for article (PubMed ID: 16278936)
1. Dissection of the molecular basis of mycophenolate resistance in Saccharomyces cerevisiae.
Jenks MH; Reines D
Yeast; 2005 Nov; 22(15):1181-90. PubMed ID: 16278936
[TBL] [Abstract][Full Text] [Related]
2. Functional distinctions between IMP dehydrogenase genes in providing mycophenolate resistance and guanine prototrophy to yeast.
Hyle JW; Shaw RJ; Reines D
J Biol Chem; 2003 Aug; 278(31):28470-8. PubMed ID: 12746440
[TBL] [Abstract][Full Text] [Related]
3. Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo.
McPhillips CC; Hyle JW; Reines D
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12171-6. PubMed ID: 15292516
[TBL] [Abstract][Full Text] [Related]
4. IMP dehydrogenase is recruited to the transcription complex through serine 2 phosphorylation of RNA polymerase II.
Park JH; Ahn SH
Biochem Biophys Res Commun; 2010 Feb; 392(4):588-92. PubMed ID: 20097157
[TBL] [Abstract][Full Text] [Related]
5. Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.
Shaw RJ; Wilson JL; Smith KT; Reines D
J Biol Chem; 2001 Aug; 276(35):32905-16. PubMed ID: 11441018
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of the IMD2 gene mediated by the transcriptional co-activator Sub1.
Koyama H; Sumiya E; Nagata M; Ito T; Sekimizu K
Genes Cells; 2008 Nov; 13(11):1113-26. PubMed ID: 18823333
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces cerevisiae transcription elongation mutants are defective in PUR5 induction in response to nucleotide depletion.
Shaw RJ; Reines D
Mol Cell Biol; 2000 Oct; 20(20):7427-37. PubMed ID: 11003640
[TBL] [Abstract][Full Text] [Related]
8. Large-scale screening of yeast mutants for sensitivity to the IMP dehydrogenase inhibitor 6-azauracil.
Riles L; Shaw RJ; Johnston M; Reines D
Yeast; 2004 Feb; 21(3):241-8. PubMed ID: 14968429
[TBL] [Abstract][Full Text] [Related]
9. A study of biochemical and functional interactions of Htl1p, a putative component of the Saccharomyces cerevisiae, Rsc chromatin-remodeling complex.
Florio C; Moscariello M; Ederle S; Fasano R; Lanzuolo C; Pulitzer JF
Gene; 2007 Jun; 395(1-2):72-85. PubMed ID: 17400406
[TBL] [Abstract][Full Text] [Related]
10. The critical cis-acting element required for IMD2 feedback regulation by GDP is a TATA box located 202 nucleotides upstream of the transcription start site.
Escobar-Henriques M; Daignan-Fornier B; Collart MA
Mol Cell Biol; 2003 Sep; 23(17):6267-78. PubMed ID: 12917347
[TBL] [Abstract][Full Text] [Related]
11. The YCR079w gene confers a rapamycin-resistant function and encodes the sixth type 2C protein phosphatase in Saccharomyces cerevisiae.
Ruan H; Yan Z; Sun H; Jiang L
FEMS Yeast Res; 2007 Mar; 7(2):209-15. PubMed ID: 17002782
[TBL] [Abstract][Full Text] [Related]
12. Transcription initiation of the yeast IMD2 gene is abolished in response to nutrient limitation through a sequence in its coding region.
Escobar-Henriques M; Collart MA; Daignan-Fornier B
Mol Cell Biol; 2003 Sep; 23(17):6279-90. PubMed ID: 12917348
[TBL] [Abstract][Full Text] [Related]
13. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.
Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J
Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550
[TBL] [Abstract][Full Text] [Related]
14. De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans.
Morrow CA; Valkov E; Stamp A; Chow EW; Lee IR; Wronski A; Williams SJ; Hill JM; Djordjevic JT; Kappler U; Kobe B; Fraser JA
PLoS Pathog; 2012; 8(10):e1002957. PubMed ID: 23071437
[TBL] [Abstract][Full Text] [Related]
15. A novel role for Bsd2 in the resistance of yeast to adriamycin.
Takahashi T; Furuchi T; Naganuma A
J Cell Physiol; 2005 Jan; 202(1):100-4. PubMed ID: 15389553
[TBL] [Abstract][Full Text] [Related]
16. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO
J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of mitochondrial response to arsenic in yeast Saccharomyces cerevisiae.
Vujcic M; Shroff M; Singh KK
Cancer Res; 2007 Oct; 67(20):9740-9. PubMed ID: 17942904
[TBL] [Abstract][Full Text] [Related]
18. The Hsp90/Cdc37p chaperone system is a determinant of molybdate resistance in Saccharomyces cerevisiae.
Millson SH; Nuttall JM; Mollapour M; Piper PW
Yeast; 2009 Jun; 26(6):339-47. PubMed ID: 19399909
[TBL] [Abstract][Full Text] [Related]
19. IMP dehydrogenase from Pneumocystis carinii as a potential drug target.
O'Gara MJ; Lee CH; Weinberg GA; Nott JM; Queener SF
Antimicrob Agents Chemother; 1997 Jan; 41(1):40-8. PubMed ID: 8980752
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acid residues essential for the yeast N-acetyltransferase Mpr1 activity by site-directed mutagenesis.
Kotani T; Takagi H
FEMS Yeast Res; 2008 Jun; 8(4):607-14. PubMed ID: 18373682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
